{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:33Z","timestamp":1792788273929,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["82503123"],"award-info":[{"award-number":["82503123"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Postdoctoral Fellowship Program of CPSF","award":["GZC20241497"],"award-info":[{"award-number":["GZC20241497"]}]},{"name":"the China Postdoctoral Science Foundation funded project","award":["2024M762860"],"award-info":[{"award-number":["2024M762860"]}],"id":[{"id":"https:\/\/ror.org\/0426zh255","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the programs of Zhejiang Traditional Chinese Medicine Innovation Team","award":["CZ2024009"],"award-info":[{"award-number":["CZ2024009"]}]},{"name":"Joint TCM Science & Technology Projects of National Demonstration Zones for Comprehensive TCM Reform","award":["GZY-ZJ-KJ-24034"],"award-info":[{"award-number":["GZY-ZJ-KJ-24034"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02180-0","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:14:29Z","timestamp":1782472469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BTN3A1 regulate the function of V\u03b39V\u03b42 T cells through TCR signaling pathway in ovarian cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Jian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"4","key":"2180_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. Cancer J Clin. 2018;68(4):284\u201396. https:\/\/doi.org\/10.3322\/caac.21456.","journal-title":"Cancer J Clin"},{"key":"2180_CR2","doi-asserted-by":"publisher","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A, Cancer statistics. 2025. CA: A Cancer Journal for Clinicians. 2025;75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871","DOI":"10.3322\/caac.21871"},{"issue":"9","key":"2180_CR3","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","volume":"4","author":"PA Konstantinopoulos","year":"2023","unstructured":"Konstantinopoulos PA, Matulonis UA. Clinical and translational advances in ovarian cancer therapy. Nat Cancer. 2023;4(9):1239\u201357. https:\/\/doi.org\/10.1038\/s43018-023-00617-9.","journal-title":"Nat Cancer"},{"issue":"3","key":"2180_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa020177","volume":"348","author":"L Zhang","year":"2003","unstructured":"Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med. 2003;348(3):203\u201313. https:\/\/doi.org\/10.1056\/NEJMoa020177.","journal-title":"N Engl J Med"},{"key":"2180_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ygyno.2024.04.001","volume":"186","author":"SB Gitto","year":"2024","unstructured":"Gitto SB, Ihewulezi CJN, Powell DJ. Jr. Adoptive T cell therapy for ovarian cancer. Gynecol Oncol. 2024;186:77\u201384. https:\/\/doi.org\/10.1016\/j.ygyno.2024.04.001.","journal-title":"Gynecol Oncol"},{"key":"2180_CR6","doi-asserted-by":"publisher","unstructured":"Nasiri F, Farrokhi K, Safarzadeh Kozani P, Mahboubi Kancha M, Dashti Shokoohi S, Safarzadeh Kozani P. CAR-T cell immunotherapy for ovarian cancer: hushing the silent killer. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1302307.","DOI":"10.3389\/fimmu.2023.1302307"},{"issue":"5732","key":"2180_CR7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1126\/science.1110267","volume":"309","author":"M Brandes","year":"2005","unstructured":"Brandes M, Willimann K, Moser B. Professional antigen-presentation function by human gammadelta T Cells. Science. 2005;309(5732):264\u20138. https:\/\/doi.org\/10.1126\/science.1110267.","journal-title":"Science"},{"key":"2180_CR8","doi-asserted-by":"publisher","unstructured":"Maniar A, Zhang X, Fau - Lin W, Lin W, Fau -. Gastman BR, Gastman Br Fau - Pauza CD, Pauza Cd Fau - Strome SE, Strome Se Fau - Chapoval AI, Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement. Blood. 116(10):1726\u201333. https:\/\/doi.org\/10.1182\/blood-2009-07-234211.","DOI":"10.1182\/blood-2009-07-234211"},{"issue":"3","key":"2180_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41571-022-00722-1","volume":"20","author":"S Mensurado","year":"2023","unstructured":"Mensurado S, Blanco-Dom\u00ednguez R, Silva-Santos B. The emerging roles of \u03b3\u03b4 T cells in cancer immunotherapy. Nat Reviews Clin Oncol. 2023;20(3):178\u201391. https:\/\/doi.org\/10.1038\/s41571-022-00722-1.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"1","key":"2180_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12943-023-01722-0","volume":"22","author":"Z Gao","year":"2023","unstructured":"Gao Z, Bai Y, Lin A, Jiang A, Zhou C, Cheng Q, et al. Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment. Mol Cancer. 2023;22(1):31. https:\/\/doi.org\/10.1186\/s12943-023-01722-0.","journal-title":"Mol Cancer"},{"issue":"4","key":"2180_CR11","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/annonc\/mdi112","volume":"16","author":"MR Raspollini","year":"2005","unstructured":"Raspollini MR, Castiglione F, Rossi Degl\u2019Innocenti D, Amunni G, Villanucci A, Garbini F, et al. Tumour-infiltrating gamma\/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma. Ann Oncol. 2005;16(4):590\u20136. https:\/\/doi.org\/10.1093\/annonc\/mdi112.","journal-title":"Ann Oncol"},{"key":"2180_CR12","doi-asserted-by":"publisher","unstructured":"Mao TL, Miao CH, Liao YJ, Chen YJ, Yeh CY, Liu CL. Ex Vivo Expanded Human V\u03b39V\u03b42 T-Cells Can Suppress Epithelial Ovarian Cancer Cell Growth. Int J Mol Sci. 2019;20(5). https:\/\/doi.org\/10.3390\/ijms20051139.","DOI":"10.3390\/ijms20051139"},{"key":"2180_CR13","doi-asserted-by":"publisher","unstructured":"Chen X, Shang W, Xu R, Wu M, Zhang X, Huang P, et al. Distribution and functions of \u03b3\u03b4 T cells infiltrated in the ovarian cancer microenvironment. J Translational Med. 2019;17(1). https:\/\/doi.org\/10.1186\/s12967-019-1897-0.","DOI":"10.1186\/s12967-019-1897-0"},{"key":"2180_CR14","doi-asserted-by":"publisher","unstructured":"Weimer P, Wellbrock J, Sturmheit T, Oliveira-Ferrer L, Ding Y, Menzel S, et al. Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by gammadelta T Cells in Ovarian Cancer. Cells. 2022;11(6). https:\/\/doi.org\/10.3390\/cells11060964.","DOI":"10.3390\/cells11060964"},{"key":"2180_CR15","doi-asserted-by":"publisher","unstructured":"H\u00e4nzelmann S, Castelo R, Fau - Guinney J, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC bioinformatics. 14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","DOI":"10.1186\/1471-2105-14-7"},{"issue":"4","key":"2180_CR16","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, et al. Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer. Immunity. 2013;39(4):782\u201395. https:\/\/doi.org\/10.1016\/j.immuni.2013.10.003.","journal-title":"Immunity"},{"key":"2180_CR17","doi-asserted-by":"publisher","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nature Communications. 2013;4(2041\u2009\u2013\u20091723). https:\/\/doi.org\/10.1038\/ncomms3612. (Electronic). ARTN2612.","DOI":"10.1038\/ncomms3612"},{"issue":"12","key":"2180_CR18","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"issue":"5","key":"2180_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"issue":"17","key":"2180_CR20","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/bioinformatics\/btv300","volume":"31","author":"W Walter","year":"2015","unstructured":"Walter W, S\u00e1nchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31(17):2912\u20134.  https:\/\/doi.org\/10.1093\/bioinformatics\/btv300.","journal-title":"Bioinformatics"},{"key":"2180_CR21","doi-asserted-by":"publisher","unstructured":"Liu ZQ, Liu L, Weng SY, Xu H, Xing Z, Ren YQ et al. BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors. J Big Data-Ger. 2023;10(1). https:\/\/doi.org\/10.1186\/s40537-023-00844-y. ARTN165.","DOI":"10.1186\/s40537-023-00844-y"},{"key":"2180_CR22","doi-asserted-by":"publisher","unstructured":"Cui H, Zhao G, Lu Y, Zuo S, Duan D, Luo X et al. TIMER3: an enhanced resource for tumor immune analysis. Nucleic acids research. 53(W1):W534\u2013W541. https:\/\/doi.org\/10.1093\/nar\/gkaf388.","DOI":"10.1093\/nar\/gkaf388"},{"key":"2180_CR23","doi-asserted-by":"publisher","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences. 2005;102(43):15545-50. https:\/\/doi.org\/10.1073\/pnas.0506580102.","DOI":"10.1073\/pnas.0506580102"},{"issue":"8","key":"2180_CR24","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","volume":"21","author":"AJ Gentles","year":"2015","unstructured":"Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. 2015;21(8):938\u201345. https:\/\/doi.org\/10.1038\/nm.3909.","journal-title":"Nat Med"},{"key":"2180_CR25","doi-asserted-by":"publisher","unstructured":"Foord E, Arruda LCM, Gaballa A, Klynning C, Uhlin M. Characterization of ascites- and tumor-infiltrating \u03b3\u03b4 T cells reveals distinct repertoires and a beneficial role in ovarian cancer. Sci Transl Med. 2021;13(577). https:\/\/doi.org\/10.1126\/scitranslmed.abb0192. ARTNeabb0192.","DOI":"10.1126\/scitranslmed.abb0192"},{"key":"2180_CR26","doi-asserted-by":"publisher","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;2612. https:\/\/doi.org\/10.1038\/ncomms3612. 4(2041\u2009\u2013\u20091723 (Electronic)).","DOI":"10.1038\/ncomms3612"},{"key":"2180_CR27","doi-asserted-by":"publisher","unstructured":"Rigau M, Ostrouska S, Fulford TS, Johnson DN, Woods K, Ruan Z, et al. Butyrophilin 2A1 is essential for phosphoantigen reactivity by \u03b3\u03b4 T cells. Science. 2020;367(6478). https:\/\/doi.org\/10.1126\/science.aay5516.","DOI":"10.1126\/science.aay5516"},{"issue":"9","key":"2180_CR28","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/ni.2665","volume":"14","author":"S Vavassori","year":"2013","unstructured":"Vavassori S, Kumar A, Wan GS, Ramanjaneyulu GS, Cavallari M, El Daker S, et al. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human gammadelta T cells. Nat Immunol. 2013;14(9):908\u201316. https:\/\/doi.org\/10.1038\/ni.2665.","journal-title":"Nat Immunol"},{"issue":"35","key":"2180_CR29","doi-asserted-by":"publisher","first-page":"E7311","DOI":"10.1073\/pnas.1707547114","volume":"114","author":"SY Gu","year":"2017","unstructured":"Gu SY, Sachleben JR, Boughter CT, Nawrocka WI, Borowska MT, Tarrasch JT, et al. Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on V\u03b39V\u03b42 T cell activation. P Natl Acad Sci USA. 2017;114(35):E7311\u201320. https:\/\/doi.org\/10.1073\/pnas.1707547114.","journal-title":"P Natl Acad Sci USA"},{"issue":"6506","key":"2180_CR30","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1126\/science.aay2767","volume":"369","author":"KK Payne","year":"2020","unstructured":"Payne KK, Mine JA, Biswas S, Chaurio RA, Perales-Puchalt A, Anadon CM, et al. BTN3A1 governs antitumor responses by coordinating \u03b1\u03b2 and \u03b3\u03b4 T cells. Science. 2020;369(6506):942\u20139. https:\/\/doi.org\/10.1126\/science.aay2767.","journal-title":"Science"},{"issue":"6","key":"2180_CR31","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","volume":"35","author":"R Wang","year":"2011","unstructured":"Wang R, Dillon Christopher P, Shi Lewis Z, Milasta S, Carter R, Finkelstein D, et al. The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation. Immunity. 2011;35(6):871\u201382. https:\/\/doi.org\/10.1016\/j.immuni.2011.09.021.","journal-title":"Immunity"},{"issue":"14","key":"2180_CR32","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1182\/blood-2012-07-442962","volume":"121","author":"LM Kuijk","year":"2013","unstructured":"Kuijk LM, Verstege MI, Rekers NV, Bruijns SC, Hooijberg E, Roep BO, et al. Notch controls generation and function of human effector CD8\u2009+\u2009T cells. Blood. 2013;121(14):2638\u201346. https:\/\/doi.org\/10.1182\/blood-2012-07-442962.","journal-title":"Blood"},{"key":"2180_CR33","doi-asserted-by":"publisher","first-page":"624122","DOI":"10.3389\/fendo.2020.624122","volume":"11","author":"L Odagiu","year":"2020","unstructured":"Odagiu L, May J, Boulet S, Baldwin TA, Labrecque N. Role of the Orphan Nuclear Receptor NR4A Family in T-Cell Biology. Front Endocrinol (Lausanne). 2020;11:624122. https:\/\/doi.org\/10.3389\/fendo.2020.624122.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7749","key":"2180_CR34","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41586-019-0985-x","volume":"567","author":"J Chen","year":"2019","unstructured":"Chen J, Lopez-Moyado IF, Seo H, Lio CJ, Hempleman LJ, Sekiya T, et al. NR4A transcription factors limit CAR T cell function in solid tumours. Nature. 2019;567(7749):530\u20134. https:\/\/doi.org\/10.1038\/s41586-019-0985-x.","journal-title":"Nature"},{"issue":"3","key":"2180_CR35","first-page":"277","volume":"15","author":"YH Gan","year":"2001","unstructured":"Gan YH, Wallace M, Malkovsky M. Fas-dependent, activation-induced cell death of gammadelta cells. J Biol Regul Homeost Agents. 2001;15(3):277\u201385.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"6","key":"2180_CR36","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/JLB.5MR0722-777R","volume":"112","author":"D Chen","year":"2022","unstructured":"Chen D, Guo Y, Jiang J, Wu P, Zhang T, Wei Q, et al. gammadelta T cell exhaustion: Opportunities for intervention. J Leukoc Biol. 2022;112(6):1669\u201376. https:\/\/doi.org\/10.1002\/JLB.5MR0722-777R.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"2180_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/cmi.2011.28","volume":"9","author":"H Zhao","year":"2011","unstructured":"Zhao H, Xi X, Cui L, He W. CDR3\u03b4 -grafted \u03b39\u03b42T cells mediate effective antitumor reactivity. Cell Mol Immunol. 2011;9(2):147\u201354. https:\/\/doi.org\/10.1038\/cmi.2011.28.","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"2180_CR38","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.canlet.2008.07.015","volume":"272","author":"Z Wang","year":"2008","unstructured":"Wang Z, Zhang T, Hu H, Zhang H, Yang Z, Cui L, et al. Targeting solid tumors via T cell receptor complementarity-determining region 3\u03b4 in an engineered antibody. Cancer Lett. 2008;272(2):242\u201352. https:\/\/doi.org\/10.1016\/j.canlet.2008.07.015.","journal-title":"Cancer Lett"},{"issue":"11","key":"2180_CR39","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.4049\/jimmunol.1402200","volume":"193","author":"AC Parente-Pereira","year":"2014","unstructured":"Parente-Pereira AC, Shmeeda H, Whilding LM, Zambirinis CP, Foster J, van der Stegen SJC, et al. Adoptive Immunotherapy of Epithelial Ovarian Cancer with V\u03b39V\u03b42 T Cells, Potentiated by Liposomal Alendronic Acid. J Immunol. 2014;193(11):5557\u201366. https:\/\/doi.org\/10.4049\/jimmunol.1402200.","journal-title":"J Immunol"},{"issue":"2","key":"2180_CR40","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.canlet.2013.07.036","volume":"341","author":"J Zheng","year":"2013","unstructured":"Zheng J, Guo Y, Ji X, Cui L, He W. A novel antibody-like TCR\u03b3\u03b4-Ig fusion protein exhibits antitumor activity against human ovarian carcinoma. Cancer Lett. 2013;341(2):150\u20138. https:\/\/doi.org\/10.1016\/j.canlet.2013.07.036.","journal-title":"Cancer Lett"},{"key":"2180_CR41","doi-asserted-by":"publisher","unstructured":"Ferrini S, Prigione I, Fau - Mammoliti S, Mammoliti S, Fau - Colnaghi MI, Colnaghi Mi Fau - M\u00e9nard S, M\u00e9nard S, Fau - Moretta A, Moretta A, Fau - Moretta L et al. Re-targeting of human lymphocytes expressing the T-cell receptor gamma\/delta to ovarian carcinoma cells by the use of bispecific monoclonal antibodies. Int J Cancer. 44(2):245\u201350. https:\/\/doi.org\/10.1002\/ijc.2910440210.","DOI":"10.1002\/ijc.2910440210"},{"issue":"Print","key":"2180_CR42","doi-asserted-by":"publisher","first-page":"0105","DOI":"10.1111\/j.1600-065X.2007.00527.x","volume":"218","author":"BJ Burbach","year":"2007","unstructured":"Burbach BJ, Medeiros RB, Mueller KL, Shimizu Y. T-cell receptor signaling to integrins. Immunol Rev. 2007;218(Print):0105\u20132896. https:\/\/doi.org\/10.1111\/j.1600-065X.2007.00527.x.","journal-title":"Immunol Rev"},{"issue":"6506","key":"2180_CR43","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1126\/science.aay2767","volume":"369","author":"KK Payne","year":"2020","unstructured":"Payne KK, Mine JA, Biswas S, Chaurio RA, Perales-Puchalt A, Anadon CM, et al. BTN3A1 governs antitumor responses by coordinating alphabeta and gammadelta T cells. Science. 2020;369(6506):942\u20139. https:\/\/doi.org\/10.1126\/science.aay2767.","journal-title":"Science"},{"key":"2180_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401230","author":"M Wu","year":"2025","unstructured":"Wu M, Liu J, Liu L, Yang Y, Liu H, Yu L, et al. Autologous Peripheral V\u03b39V\u03b42 T Cell Synergizes with \u03b1\u03b2 T Cell Through Antigen Presentation and BTN3A1 Blockade in Immunotherapy of Cervical Cancer. Adv Sci. 2025. https:\/\/doi.org\/10.1002\/advs.202401230.","journal-title":"Adv Sci"},{"key":"2180_CR45","doi-asserted-by":"publisher","unstructured":"Rei M, Gon\u00e7alves-Sousa N, Lan\u00e7a T, Thompson RG, Mensurado S, Balkwill FR et al. Murine CD27(\u2013) V\u03b36(+) \u03b3\u03b4 T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages. Proceedings of the National Academy of Sciences. 2014;111(34):E3562-E70. https:\/\/doi.org\/10.1073\/pnas.1403424111.","DOI":"10.1073\/pnas.1403424111"},{"key":"2180_CR46","doi-asserted-by":"publisher","unstructured":"Kone AS, Ait Ssi S, Sahraoui S, Badou A. BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment. Int J Mol Sci. 2022;23(21). https:\/\/doi.org\/10.3390\/ijms232113424.","DOI":"10.3390\/ijms232113424"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02180-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02180-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02180-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:41:40Z","timestamp":1789598500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02180-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2180"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02180-0","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"286"}}